EP Patent

EP0226679A1 — Contraceptive method and kit

Assigned to Warner Lambert Co LLC · Expires 1987-07-01 · 39y expired

What this patent protects

Contraceptive methods and delivery systems involving few undesirable side effects during administration are based on novel estrogen/progestogen combinations and multiphase administration sequences.

USPTO Abstract

Contraceptive methods and delivery systems involving few undesirable side effects during administration are based on novel estrogen/progestogen combinations and multiphase administration sequences.

Drugs covered by this patent

Patent Metadata

Patent number
EP0226679A1
Jurisdiction
EP
Classification
—
Expires
1987-07-01
Drug substance claim
No
Drug product claim
No
Assignee
Warner Lambert Co LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.